OHSU

Andy Chen, M.D., Ph.D.

Head Shot of Andy Chen
Email: 
click here
Office: 
503 494-5058

Background

Dr. Chen provides care for patients with hematologic malignancies, particularly those with lymphoma or who are undergoing transplant. He has a basic science background in immunology, and his research now focuses on clinical trials of novel therapies and transplantation for aggressive lymphoma.


Selected Publications

"Aberrations of MYC are a common event in B-cell prolymphocytic leukemia," American Journal of Clinical Pathology (Vol: 142, Issue: 3, Page 347-354) - 2014

"Early Failure of Frontline Rituximab-Containing Chemo-immunotherapy in Diffuse Large B Cell Lymphoma Does Not Predict Futility of Autologous Hematopoietic Cell Transplantation," Biology of Blood and Marrow Transplantation (Vol: 20, Issue: 11, Page 1729-1736) - 2014

"Early Failure of Frontline Rituximab-Containing Chemo-immunotherapy in Diffuse Large B Cell Lymphoma Does Not Predict Futility of Autologous Hematopoietic Cell Transplantation," Biology of Blood and Marrow Transplantation - 2014

"Improved outcome with busulfan, melphalan and thiotepa conditioning in autologous hematopoietic stem cell transplant for relapsed/refractory Hodgkin lymphoma," Leukemia and Lymphoma (Vol: 55, Issue: 3, Page 583-587) - 2014

"Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement," British Journal of Haematology (Vol: 162, Issue: 5, Page 648-656) - 2013

 

OHSU Knight Cancer Institute

Visit Our Site

For Healthcare Professionals


Contact

  Email Andy Chen

503 494-5058

Memberships & Associations

American Society of Hematology American Society of Clinical Oncology American Society of Blood and Marrow Transplantation